Amit Patel

Amit Patel

Opinion author

Amit Patel is the vice president of Strategic Initiatives and Operations, Enterprise Medical Solutions at Indegene. Previously, he served as a partner at Medical Marketing Economics, LLC, a strategic pricing consulting and research firm.

Dr. Patel is a biopharma market access, pricing and reimbursement expert who helps biopharmaceutical companies in developing optimal launch, market access, pricing and reimbursement strategies and tactics. He has experience in a broad array of disease and therapeutic areas involving large and small molecules. With training in pharmacy, pharmaceutical marketing and marketing research, Dr. Patel leads projects that help examine product-level clinical and economic value, demand, pricing and sales.

Dr. Patel has several peer-reviewed publications and has published in multiple areas including physician and patient decision-making, health economics, price controls, customer relationship marketing, marketing ethics and policy. He has adjunct professor positions at the University of Mississippi and the University of Southern California.

Dr. Patel holds a Bachelor of Pharmacy from the University of Mumbai, MET Institute of Pharmacy; an MS in Pharmaceutical Marketing from St. John’s University, New York; and a PhD in Pharmaceutical Sciences from the University of Mississippi.

Despite substantial investments in groundbreaking treatments, companies struggle to communicate value early and to the right audience. Here’s how they can do better.